Skip Ribbon Commands
Skip to main content

News

 

 

Terumo Corporation and Diabeloop SA. Enter into Comprehensive Strategic Partnership Agreement to Expand Their Diabetes Care Offeringhttps://www.terumo-europe.com/en-emea/news/terumo-corporation-and-diabeloop-sa-enter-into-comprehensive-strategic-partnership-agreement-to-expand-their-diabetes-careTerumo Corporation and Diabeloop SA. Enter into Comprehensive Strategic Partnership Agreement to Expand Their Diabetes Care OfferingTOKYO, JAPAN and PARIS, FRANCE11/16/2021 11:00:00 PM<h4 style="text-align:justify;">​Terumo Corporation, a global leader in medical technology and the French company Diabeloop, a pioneer in therapeutic AI, announced today that they have signed an agreement for a comprehensive strategic partnership. With this agreement, in addition to the current joint development of the AID system for Japan, they will work closely to bring Automated Insulin Delivery solutions to Europe with potential further global expansion.<br><br></h4>
Terumo to Develop Smartphone-type Device to Control Insulin Pumphttps://www.terumo-europe.com/en-emea/news/terumo-to-develop-smartphone-type-device-to-control-insulin-pumpTerumo to Develop Smartphone-type Device to Control Insulin PumpTOKYO, JAPAN11/7/2021 11:00:00 PM<h4 style="text-align:justify;">​Terumo Corporation (TSE: 4543) today announced that it has partnered with an European company to co-develop a new technology to enable MEDISAFE WITH insulin patch pump to be controlled by a smartphone-type device. With this upgrade, Terumo aims to enhance the operability of MEDISAFE WITH as well as allowing insulin pump therapy to be harmonized into the day-to-day life of people with diabetes. The smartphone-type device will be dedicated to controlling the MEDISAFE WITH.</h4><h4><br></h4>
Terumo Celebrates 100th Anniversary of Contributing to Society Through Healthcarehttps://www.terumo-europe.com/en-emea/news/terumo-celebrates-100th-anniversary-of-contributing-to-society-through-healthcareTerumo Celebrates 100th Anniversary of Contributing to Society Through HealthcareTOKYO, JAPAN9/16/2021 10:00:00 PM<p>​Terumo Corporation (TSE: 4543), a global leader in medical technology, today celebrates its 100th anniversary. The company, based in Tokyo, boasts over 25,000 associates worldwide, providing products and services to more than 160 countries and regions across the globe. <br></p>
MASTER DAPT, a landmark trial on abbreviated DAPT post-implantation of Ultimaster™ DES in HBR patientshttps://www.terumo-europe.com/en-emea/news/master-dapt-a-landmark-trial-on-abbreviated-dapt-post-implantation-of-ultimaster™-des-in-hbr-patientsMASTER DAPT, a landmark trial on abbreviated DAPT post-implantation of Ultimaster™ DES in HBR patientsLEUVEN, BELGIUM8/29/2021 10:00:00 PM<p>​<span style="letter-spacing:-0.1px;">Final results released @ ESC 2021 and simultaneously published in New England Journal of Medicine and Circulation</span><br></p>
Terumo and UMCU strengthen their partnership to develop solutions in Interventional Oncologyhttps://www.terumo-europe.com/en-emea/news/terumo-and-umcu-strengthen-their-partnership-to-develop-solutions-in-interventional-oncologyTerumo and UMCU strengthen their partnership to develop solutions in Interventional OncologyDeventer, Tokyo, Utrecht7/18/2021 10:00:00 PM<p>​Terumo Europe and University Medical Center Utrecht signed a Memorandum of Understanding<br></p>